Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

Clinical trial NCT07226219 · RECRUITING

Trial details

NCT number: NCT07226219
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease Executive Dysfunction Cognitive Impairment Attention Deficit/Hyperactivity Disorder (ADHD)

Start date: 2025-11-25
Primary completion: 2027-07-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.